跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
全球衛生暨衛生安全碩士學位學程
臺北醫學大學
公共衛生學院
電話
+886-2-27361661#6626
電子郵件
[email protected]
網站
https://global.tmu.edu.tw/
郵寄地址
在地圖上顯示
No. 250 Wu-Xing Street
11031
Taipei
概覽
指紋
網路
專家檔案
(12)
專案
(99)
研究成果
(1905)
資料集
(58)
指紋
查看啟用 全球衛生暨衛生安全碩士學位學程 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Meta-Analysis
100%
Systematic Review
72%
Randomized Controlled Trial
64%
Cohort Analysis
32%
Apoplexy
25%
Breast Cancer
25%
Disease
24%
Infection
21%
Odds Ratio
21%
Malignant Neoplasm
21%
Prevalence
20%
Injury
16%
Chronic Kidney Disease
15%
Diabetes
14%
Hazard Ratio
13%
Brain Ischemia
12%
COVID-19
12%
Hepatocellular Carcinoma
10%
Network Meta-Analysis
10%
Logistic Regression Analysis
10%
Health Care
9%
Health Care Cost
9%
Cohort Effect
8%
Cross Sectional Study
8%
Drug Therapy
8%
Surgeon
8%
Dietary Pattern
8%
Neoplasm
7%
Random Effects Model
7%
Postoperative Pain
7%
Quality of Life
7%
Childbirth
7%
Medicine
7%
Traumatic Brain Injury
7%
Diabetes Mellitus
7%
Maturity Onset Diabetes of the Young
7%
Cardiovascular Disease
7%
Case-Control Study
7%
Symptom
7%
Programmed Cell Death
6%
Ischemic Heart Disease
6%
Closed Head Injury
6%
Surgery
6%
Global Disease Burden
6%
Kidney Function
6%
Survival Rate
6%
Anemia
5%
Middle Age
5%
Lung Cancer
5%
Toxocariasis
5%
Cesarean Section
5%
Hernioplasty
5%
Overall Survival
5%
Human Immunodeficiency Virus
5%
Proportional Hazards Model
5%
Rehabilitation Engineering
5%
Cigarette Smoking
5%
Effect Size
5%
Analgesia
5%
Cancer Risk
5%
Traditional Chinese Medicine
5%
Supplementation
5%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
51%
Cohort Study
43%
Malignant Neoplasm
33%
Disease
31%
Mouse
20%
Breast Cancer
20%
Infection
19%
Prevalence
18%
Chronic Kidney Failure
16%
Injury
15%
Liver Cell Carcinoma
15%
Inflammation
12%
Well Water
12%
Brain Ischemia
11%
Adverse Event
10%
Diabetes Mellitus
10%
Cytotoxicity
10%
Neoplasm
9%
Antivirus Agent
9%
Antioxidant
9%
Cigarette Smoking
9%
Hepatitis C Virus
9%
Rheumatoid Arthritis
8%
Non Insulin Dependent Diabetes Mellitus
8%
Comorbidity
8%
Anti-Inflammatory Drug
8%
Overall Survival
8%
Cardiovascular Disease
8%
Lipopolysaccharide
8%
Antiinflammatory Activity
8%
Lung Cancer
8%
Symptom
7%
Head Injury
7%
Carotid Atherosclerosis
7%
Survival Rate
7%
Dose-Response Relationship
7%
Traumatic Brain Injury
7%
Mortality Rate
7%
Chemotherapy
7%
Ischemic Heart Disease
7%
Random Effects Model
7%
Transitional Cell Carcinoma
7%
Placebo
7%
Vaccination Policy
6%
Polysaccharide
6%
Headache
6%
Case-Control Study
6%
Hemodialysis
6%
Traditional Chinese Medicine
6%
Cyclooxygenase 2
6%
HIV
6%
Migraine
6%
Bladder Cancer
6%
Lycium barbarum
6%
IC50
6%
Tumor Necrosis Factor
6%
Hepatitis C
6%
Inducible Nitric Oxide Synthase
5%
Clinical Trial
5%
Biological Marker
5%
Cytokine
5%
Chronic Obstructive Lung Disease
5%
Nursing and Health Professions
Meta Analysis
78%
Systematic Review
47%
Confidence Interval
44%
Odds Ratio
19%
Cohort Analysis
19%
Breast Cancer
17%
National Health Insurance
16%
Injury
15%
Disease
14%
Quality of Life
13%
Traumatic Brain Injury
13%
Health Service
13%
Health Care Personnel
12%
Drug Therapy
12%
Hospital
12%
Cochrane Library
11%
Prevalence
11%
Practice Guideline
11%
Medline
10%
Cross-Sectional Study
10%
Logistic Regression Analysis
9%
Human Immunodeficiency Virus
9%
Health Literacy
8%
Head Injury
8%
Malignant Neoplasm
8%
Symptom
8%
Shared Decision-Making
7%
Rehabilitation Engineering
7%
World Health Organization
6%
Hazard Ratio
6%
Mortality Rate
6%
Embase
6%
Limb Injury
6%
Chronic Kidney Failure
6%
Infection
6%
Teaching Hospital
6%
Comorbidity
6%
Outpatient
6%
Health Status
5%
Multivariate Logistic Regression Analysis
5%
Long Term Care
5%
Out of Hospital Cardiac Arrest
5%
Public Hospital
5%
Clinical Practice
5%
Case-Control Study
5%